Cost-effectiveness of Korea's national cervical cancer screening program

Eun Cho, Moon Hae Kang, Kui Son Choi, Mi Na Suh, Jae Kwan Jun, Euncheol Park

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Cervical cancer, which is common in developing countries, is also a major health issue in Korea. Our aim was to evaluate the cost-effectiveness of Korea's National Cancer Screening Program (NCSP), implemented in 1999. Materials and Methods: The target population was Korean women 30 years or over who were invited to take part in the NCSP in 2002-2007. By merging NCSP records with Korean Central Cancer Registry data, patients diagnosed with cervical cancer who had been screened were assigned to a "screened group," while patients diagnosed elsewhere were assigned to a "non-screened group." Clinical outcomes were measured in terms of life-years saved (LYS), derived from 5-year mortality rates supplied by the Korean National Health Insurance Corporation and National Statistical Office. Direct and travel costs associated with screening were evaluated from the perspective of the payer, the NCSP. Results: A diagnosis via screening was associated with 2.30 LYS, and the incremental cost-effectiveness ratio (ICER) estimate for screening was 7,581,679 KW/LYS (6,727 USD/LYS). ICER estimates were lower for older patients (≥ 50 years) than younger patients (4,047,033 KW/LYS vs 5,680,793 KW/LYS). The proportion of early-stage cancers detected was 16.3% higher in the screened group. Conclusions: In light of Korea's per capita gross domestic product (32,272 USD in 2012), the current NCSP's incremental cost per LYS appears acceptable.

Original languageEnglish
Pages (from-to)4329-4334
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume14
Issue number7
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Korea
Early Detection of Cancer
Uterine Cervical Neoplasms
Cost-Benefit Analysis
Gross Domestic Product
Costs and Cost Analysis
Health Services Needs and Demand
National Health Programs
Developing Countries
Registries
Neoplasms
Mortality
Health

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Cho, Eun ; Kang, Moon Hae ; Choi, Kui Son ; Suh, Mi Na ; Jun, Jae Kwan ; Park, Euncheol. / Cost-effectiveness of Korea's national cervical cancer screening program. In: Asian Pacific Journal of Cancer Prevention. 2013 ; Vol. 14, No. 7. pp. 4329-4334.
@article{aa71fafa375e43a88316464a2d2b3046,
title = "Cost-effectiveness of Korea's national cervical cancer screening program",
abstract = "Background: Cervical cancer, which is common in developing countries, is also a major health issue in Korea. Our aim was to evaluate the cost-effectiveness of Korea's National Cancer Screening Program (NCSP), implemented in 1999. Materials and Methods: The target population was Korean women 30 years or over who were invited to take part in the NCSP in 2002-2007. By merging NCSP records with Korean Central Cancer Registry data, patients diagnosed with cervical cancer who had been screened were assigned to a {"}screened group,{"} while patients diagnosed elsewhere were assigned to a {"}non-screened group.{"} Clinical outcomes were measured in terms of life-years saved (LYS), derived from 5-year mortality rates supplied by the Korean National Health Insurance Corporation and National Statistical Office. Direct and travel costs associated with screening were evaluated from the perspective of the payer, the NCSP. Results: A diagnosis via screening was associated with 2.30 LYS, and the incremental cost-effectiveness ratio (ICER) estimate for screening was 7,581,679 KW/LYS (6,727 USD/LYS). ICER estimates were lower for older patients (≥ 50 years) than younger patients (4,047,033 KW/LYS vs 5,680,793 KW/LYS). The proportion of early-stage cancers detected was 16.3{\%} higher in the screened group. Conclusions: In light of Korea's per capita gross domestic product (32,272 USD in 2012), the current NCSP's incremental cost per LYS appears acceptable.",
author = "Eun Cho and Kang, {Moon Hae} and Choi, {Kui Son} and Suh, {Mi Na} and Jun, {Jae Kwan} and Euncheol Park",
year = "2013",
month = "1",
day = "1",
doi = "10.7314/APJCP.2013.14.7.4329",
language = "English",
volume = "14",
pages = "4329--4334",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "7",

}

Cost-effectiveness of Korea's national cervical cancer screening program. / Cho, Eun; Kang, Moon Hae; Choi, Kui Son; Suh, Mi Na; Jun, Jae Kwan; Park, Euncheol.

In: Asian Pacific Journal of Cancer Prevention, Vol. 14, No. 7, 01.01.2013, p. 4329-4334.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cost-effectiveness of Korea's national cervical cancer screening program

AU - Cho, Eun

AU - Kang, Moon Hae

AU - Choi, Kui Son

AU - Suh, Mi Na

AU - Jun, Jae Kwan

AU - Park, Euncheol

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Cervical cancer, which is common in developing countries, is also a major health issue in Korea. Our aim was to evaluate the cost-effectiveness of Korea's National Cancer Screening Program (NCSP), implemented in 1999. Materials and Methods: The target population was Korean women 30 years or over who were invited to take part in the NCSP in 2002-2007. By merging NCSP records with Korean Central Cancer Registry data, patients diagnosed with cervical cancer who had been screened were assigned to a "screened group," while patients diagnosed elsewhere were assigned to a "non-screened group." Clinical outcomes were measured in terms of life-years saved (LYS), derived from 5-year mortality rates supplied by the Korean National Health Insurance Corporation and National Statistical Office. Direct and travel costs associated with screening were evaluated from the perspective of the payer, the NCSP. Results: A diagnosis via screening was associated with 2.30 LYS, and the incremental cost-effectiveness ratio (ICER) estimate for screening was 7,581,679 KW/LYS (6,727 USD/LYS). ICER estimates were lower for older patients (≥ 50 years) than younger patients (4,047,033 KW/LYS vs 5,680,793 KW/LYS). The proportion of early-stage cancers detected was 16.3% higher in the screened group. Conclusions: In light of Korea's per capita gross domestic product (32,272 USD in 2012), the current NCSP's incremental cost per LYS appears acceptable.

AB - Background: Cervical cancer, which is common in developing countries, is also a major health issue in Korea. Our aim was to evaluate the cost-effectiveness of Korea's National Cancer Screening Program (NCSP), implemented in 1999. Materials and Methods: The target population was Korean women 30 years or over who were invited to take part in the NCSP in 2002-2007. By merging NCSP records with Korean Central Cancer Registry data, patients diagnosed with cervical cancer who had been screened were assigned to a "screened group," while patients diagnosed elsewhere were assigned to a "non-screened group." Clinical outcomes were measured in terms of life-years saved (LYS), derived from 5-year mortality rates supplied by the Korean National Health Insurance Corporation and National Statistical Office. Direct and travel costs associated with screening were evaluated from the perspective of the payer, the NCSP. Results: A diagnosis via screening was associated with 2.30 LYS, and the incremental cost-effectiveness ratio (ICER) estimate for screening was 7,581,679 KW/LYS (6,727 USD/LYS). ICER estimates were lower for older patients (≥ 50 years) than younger patients (4,047,033 KW/LYS vs 5,680,793 KW/LYS). The proportion of early-stage cancers detected was 16.3% higher in the screened group. Conclusions: In light of Korea's per capita gross domestic product (32,272 USD in 2012), the current NCSP's incremental cost per LYS appears acceptable.

UR - http://www.scopus.com/inward/record.url?scp=84885464819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885464819&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2013.14.7.4329

DO - 10.7314/APJCP.2013.14.7.4329

M3 - Article

VL - 14

SP - 4329

EP - 4334

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 7

ER -